comprehensive
Previous article:
Novavax promises a turnaround & Lilly roils the obesity market
Next article: A fraught question for the kids of Alzheimer’s: Is it coming for us?
Next article: A fraught question for the kids of Alzheimer’s: Is it coming for us?
Wikipedia
hotspot
-
European regulators recommend Amylyx's ALS drug be rejected
2025-08-12 08:46 -
Colonoscopy at 40? Study finds a possible benefit
2025-08-12 08:07 -
How clinical AI models' predictive power can degrade over time
2025-08-12 07:38 -
What's changing in Medicare's open enrollment this year?
2025-08-12 07:25 -
What would happen to your eyes if you looked at the solar eclipse?
2025-08-12 07:19 -
Peter Marks talks Operation Warp Speed for Rare Diseases
2025-08-12 06:41